Search 

OPKO Health, Inc. is a multi-national pharmaceutical and diagnostics company that aims to establish industry-leading positions in large and rapidly growing medical markets by leveraging our discovery, development, and commercialization expertise and our novel and proprietary technologies. We intend to leverage our global commercialization expertise to pursue acquisitions of commercial businesses that will both drive our growth and provide geographically diverse sales and distribution opportunities. We have and may continue to make investments in other early stage companies that we perceive to have valuable proprietary technology and significant potential to create value for OPKO as a shareholder. 

Our Focus is on Point-of-Care and Novel Molecular Diagnostics, Proprietary Pharmaceuticals, and Vaccines. Since 2009, OPKO has completed five national and international acquisitions contributing to its technology and commercial operations. 

OPKO continues to explore acquisition opportunities for complementary pharmaceuticals, compounds, technologies, and businesses. We expect our future growth to arise from leveraging our proprietary technology, development strengths, and pursuit of complementary and strategic acquisitions and investments.

Specialties

Pharmaceutical and Diagnostic Products, Medical Devices

ABOUT US

OrthoCyte Corporation, a subsidiary of BioTime, Inc., is a biotechnology company developing cell-based therapies for bone and orthopedic soft tissue diseases and injuries. OrthoCyte has a vast library of proprietary normal human progenitor stem cells to skeletal tissues including, bone, articular cartilage, intervertebral disc, tendon, and ligament, all of which are in the preclinical phase of development.

MARKET OPPORTUNITY

Many surgical procedures of the spine require bone grafts to regenerate bone that has been removed or damaged due to disease or trauma. OncoCyte is focused on working toward improving patient outcomes in the spinal orthobiologics market which is currently estimated to be over $2 billion annually in the U.S., and is expected to reach $2.7 billion annually by 2020, according to GlobalData.

OsseoMatrix OsseoMatrix design, manufacture and sell patient specific synthetic bone implants. Industry sectors Medtech Therapeutics Area Dental and Oral Health
Orthopedics/Orthopedic Surgery
Otolaryngology (Ear, Nose, Throat)
Your innovative solution

OsseoMatrix has developed a direct 3D printing process of biological ceramics which enables the manufacturing of patient specific synthetic bone implants

Which problem are you solving ?

The bioceramic implants developed by OsseoMatrix fit the anatomical complexity of cranio-maxillo-facial or orthopaedic bone losses, resulting of trauma, infection, tumor.

Target market segments

Market 1: Cranio-facial Market 2: Dental Market 3 Orthopaedic 4 Laboratories

Key value proposition

advantage 1 less invasive / advantage 2 same composition as bone / advantage 3 patient specific / advantage 4 regenerative

We provide life cycle management solutions for innovator and branded pharmaceutical, medical device, biological products manufacturers. This entails winning difficult-to-obtain patents, designing Intellectual Property strategy and enforcing intellectual property to maintain market share.

I will shortly begin to interview companies able to register and launch a new US Rx product outside the US.  Partner companies must have (a) a women's health or rheumatology sales force; (b) experience registering hormone products; and (c) the ability to move quickly. 

INNOVATIVE AND EFFICIENT SOLUTIONS IN TELEMEDICINE First international research center for advanced telemedicine services developing efficient solutions for the management of chronic diseases.   CLINICAL EXPERTISE

Based on a fifteen years experience leveraging innovative R & D solutions geared towards chronic disease patients.

  CHRONIC DISEASES

Dedicated to selected chronic diseases leading to an efficient management of the healthcare costs, enhanced patient benefits and improved quality of life.

  NETWORK

A strong value-added connected health information system and a proven expertise in home healthcare through a series of programs closely connecting patients with health professionals.

  TEAM

An international multidisciplinary team with a proven record in the areas of healthcare, patient care, connected and social computer networks, design and ergonomics and health policy issues.

  WORLDWIDE

First transatlantic organization in Applied Telemedicine, offering cost efficient solutions to healthcare payers.

  SECURITY

An expertise and proven experience implemented in Europe and complying with stringent privacy and personal information laws for personal health information at the payer, provider and patient level.

INNOVATIVE AND EFFICIENT SOLUTIONS IN TELEMEDICINE
First international research center for advanced telemedicine services developing efficient solutions for the management of chronic diseases

YOUR ONE-STOP-SHOP
FOR LOCAL & GLOBAL EXECUTIVE RECRUITMENTS

Pact & Partners is solely dedicated to Life Sciences. Within this industry, 
we cover every sector while keeping track of innovative markets. With proven expertise since 1987,
our track-record of appointments covers the full spectrum of the organizational chart.